Anti-CD22 (Pinatuzumab)-MC-MMAF ADC
This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1439955-01 0.02 mg (E-Coli)
Recombinant Chlamydia muridarum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Ask
View Details MBS1439955-02 0.02 mg (Yeast)
Recombinant Chlamydia muridarum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Ask
View Details 
MBS1439955-03 0.1 mg (E-Coli)
Recombinant Chlamydia muridarum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Ask
View Details 
MBS1439955-04 0.1 mg (Yeast)
Recombinant Chlamydia muridarum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Ask
View Details MBS1439955-05 0.02 mg (Baculovirus)
Recombinant Chlamydia muridarum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp)
Ask
View Details